
Rotator Cuff Tendinopathy Clinical Practice Guidelines (2025)
Editorial Note: These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference.
Clinical practice guidelines on the diagnosis and treatment of adults with rotator cuff tendinopathy were published in April 2025 in the Journal of Orthopaedic & Sports Physical Therapy.[1]
In place of visual estimation, an inclinometer, a goniometer, or a smartphone inclinometer/goniometer application should be employed by clinicians in the objective measurement of active and passive range of motion (ROM) of the shoulder. The unreliability and limited validity of scapular ROM measures mean that they 'should not be used by clinicians to objectively measure dynamic scapular ROM.'
Oral nonsteroidal anti-inflammatory drugs (NSAIDs) may be recommended by clinicians for short-term pain reduction in adults with rotator cuff tendinopathy.
An active rehabilitation exercise program should be prescribed or recommended by clinicians as an initial treatment for pain and disability reduction in adults with rotator cuff tendinopathy. This 'may include motor control and/or resistance training exercises with various loads.'
To aid in short-term pain reduction in adults with rotator cuff tendinopathy, spinal and/or upper limb manual therapy can be employed either by themselves 'or in combination with other interventions such as exercise.' Soft tissue techniques and/or joint mobilizations or manipulations can be included in manual therapy.
In adults with rotator cuff noncalcific tendinopathy, therapeutic ultrasound should not be used (or recommended for use) as a means of pain and disability reduction, either alone or in combination with an active rehabilitation program.
For more information, please go to Rotator Cuff Disease, Rotator Cuff Injury, and Rotator Cuff Pathology.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Bloomberg
19 minutes ago
- Bloomberg
Novo Nordisk's CagriSema Shot Tied to Greater Weight Loss at Lower Doses
Novo Nordisk A/S's next-generation obesity shot CagriSema helped patients lose weight in large studies despite only about three-quarters of the patients ever making it to the highest dose. Surprisingly, patients who chose to stick with a lower dose lost more weight on average. The studies allowed patients to stop at lower doses of the drug, an unusual option in a trial. Researchers presenting new data Sunday at the American Diabetes Association meeting in Chicago say the findings offer clues as to how the drug would be used in real life. There's a group of people who respond very well to this medicine, said Timothy Garvey, director of the Diabetes Research Center at the University of Alabama at Birmingham, who helped lead the trials.


Washington Post
26 minutes ago
- Washington Post
Top NHL draft prospect Schaefer honors late-mother in not letting personal tragedies define him
When the time comes for defenseman Matthew Schaefer to take the stage at the NHL draft inside the Peacock Theater in Los Angeles this week, the top-ranked prospect won't be climbing the stairs alone. There's no doubt in Schaefer's mind his late mother Jennifer will be accompanying him in spirit. It will stand as a joyous moment for the 17-year-old Erie Otters player celebrating the person who's been at his side for every step even after she died of cancer some 16 months ago.


Washington Post
27 minutes ago
- Washington Post
Duke's Khaman Maluach, Maryland's Derik Queen headline list of big men in upcoming NBA draft
Duke's Khaman Maluach anchored the interior for an elite defensive team that reached the Final Four. Maryland's Derik Queen was the offensive focal point for a team that reached the NCAA Tournament's second weekend. Those freshmen are the headliners among big men in the upcoming NBA draft. While there's a deep well of high-end guard prospects, the bigs have a smaller list and could produce Maluach and Queen as the lone lottery picks.